Attention

The opinions expressed by columnists are their own and do not represent our advertisers

Saturday, August 15, 2020

Yale Prof: Hydroxychloroquine Haters Spewing 'Misleading And Toxic Disinformation'

Yale epidemiology professor Harvey Risch has hit back against critics who say he's been the subject of personal attacks over his insistence that hydroxychloroquine is highly effective in treating COVID-19 if administered early in the disease's progression.

Dr. Anthony Fauci has implied that I am incompetent, notwithstanding my hundreds of highly regarded, methodologically relevant publications in peer-reviewed scientific literature. A group of my Yale colleagues has publicly intimated that I am a zealot who is perpetrating a dangerous hoax and conspiracy theory. I have been attacked in news articles by journalists who, ignorant of the full picture, have spun hit pieces from cherry-picked sources. -Harvey Risch

Risch says the personal attacks are a "dangerous distraction from the real issue of hydroxychloroquine's effectiveness, which is solidly grounded in both substantial evidence and appropriate medical decision-making logic."

He adds that there a no studies - published or in pre-print - which disprove his theory that HCQ should be used on high-risk outpatients, and that "assertions to the contrary, whether by Faucci, the FDA, or anyone else, are without foundation. They constitute misleading and toxic disinformation."

Covid-19 has 'two main stages' according to Risch, and HCQ works well in the first, but not the second, later stage of the disease:

At the first stage, it is a flu-like illness. That illness will not kill you. If you are a high-risk patient and begin treatment immediately, you will almost certainly be done with it in a few days. When not treated, high-risk patients may progress. The virus then causes severe pneumonia and attacks many organs, including the heart. In this second stage, hydroxychloroquine is not effective.

So, as Risch points out, it's important to distinguish which patients HCQ works best for; "Does it not work in those who have just started to have symptoms, or those sick enough to require hospitalization?"

Secondly, Risch notes that most low-risk patients, those below 60 with no underlying comorbidities, typically survive without treatment. High risk patients are those over the age of 60, or those with chronic conditions such as obesity, diabetes, hypertension, and immunocompromised individuals.

More

6 comments:

Anonymous said...

How much more anecdotal and scientific proof is needed before treatment with this obviously effective and low risk medication is allowed to be used in otherwise uncompromised COVID patients. The detractors have scant evidence against its use, but their opinions seem to matter more.

Anonymous said...

No one and nothing is preventing physicians from prescribing this drug.

Anonymous said...

Is Yale jealous? I thought that was their job to indoctrinate young minds who would be shaped into newly minted Liberals. Haaaaaaaaaaaaa!

Anonymous said...

Dr. Stella Immanuel highly recommends it. I’m not sure if her recommendation only covers CV19 or if it extends to demonic sex issues and alien DNA issues as well.

anonymous said...

Yes Drs can not get hydroxicloraquine when wanting to prescribe it to a patient. My cousin would be alive today if it was prescribed to him early.

Anonymous said...

Yale is by and large a conservative school. George W Bush went to Yale. The school is full of old money, New England blue bloods.

You just claim every college is full of SJWs and liberals to feel superior despite not having an education.